| Bioactivity | YGZ-331 is a sedative with a calming effect. YGZ-331 is a derivative of the adenosine nucleoside NGBA, which can increase GABA levels. YGZ-331 exerts a sedative-hypnotic effect by activating A1R and A2aR, and inhibiting CaMKII phosphorylation (pCaMKII) levels. YGZ-331 can reduce the spontaneous motor activity of mice[1]. |
| CAS | 1350113-04-0 |
| Formula | C19H23N5O4 |
| Molar Mass | 385.42 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Tang B, et al. The mechanism study of YZG-331 on sedative and hypnotic effects[J]. Behavioural Brain Research, 2022, 428: 113885. |